How VytlAIQ turns pharmacy data into decisions

By Heather Brooks, Vice President, Pharmacy Services Products, VytlOne

How does AI improve pharmacy analytics for health systems? AI connects the data scattered across a health system’s pharmacy programs, from EMRs, third-party administrators, dispensing systems, and patient management platforms to 340B platforms, and normalizes it into one continuously updated view. That lets leaders see performance in real time, catch problems early, spot missed 340B and specialty opportunities, and make strategic decisions from clean data instead of manual reports. VytlAIQ is VytlOne’s AI-powered intelligence platform built to do exactly this for 340B, outpatient retail, specialty, and clinic-owned pharmacy programs.

Health system leaders overseeing 340B programs and outpatient pharmacy operations are managing some of the most complex, data-intensive work in healthcare. They are responsible for seeing that 340B savings flow back to the communities they serve, that outpatient retail and specialty pharmacies are retaining patients, and that clinic-owned pharmacy programs are reaching their full potential. The challenge has never been the availability of data. It has always been the ability to make sense of it quickly enough to act. VytlAIQ gives leaders real-time analytics, predictive insights, and decision-support tools built for exactly that complexity.

The five ways at a glance

• AI unifies data from every pharmacy system into one real-time view.
• AI catches performance signals early, while they are still easy to fix.
• AI surfaces missed 340B, retail, and specialty opportunities.
• AI flags patient leakage before a patient is lost.
• AI supports strategic decisions with clean, interpreted data.

1. AI brings all your pharmacy program data into one platform

Meaningful insight starts with complete data, and for health system pharmacy programs, that data lives in many places at once. A common frustration among pharmacy leaders is how long it takes to get a clear, reliable picture of program performance. Reports are often built manually, arrive on a lag, and require significant interpretation before they can inform a decision. Electronic medical records, third-party administrators, pharmacy dispensing systems, patient management platforms, and 340B platforms each hold a piece of the picture. Without a way to connect them, leaders make decisions on partial information or spend hours manually pulling data before analysis can begin.

VytlAIQ was built to solve that at the foundation. The platform ingests data from all of these source systems, normalizes it, and presents it through a single access point designed for health system pharmacy leadership. Rather than navigating multiple reports from multiple systems, leaders log into one platform and see a unified view of how their 340B, outpatient retail, and specialty pharmacy programs are performing. Because the data is consolidated and continuously updated, the dashboards reflect what is happening now, not what was happening when the last report ran. When something needs attention, it is visible. When programs are on track, that is visible too. The result is a leadership team that spends less time gathering data and more time acting on it.

2. AI turns data signals into early action

In health system pharmacy, the difference between a manageable issue and a major operational problem often comes down to timing. By the time a downward trend appears in a monthly report, the window for easy correction has usually passed. VytlAIQ closes that gap by identifying signals in the data early, while there is still time to act without disruption.

The platform continuously monitors performance indicators across all pharmacy program types, looking for patterns that precede problems rather than documenting them after the fact. A gradual decline in 340B-eligible prescription capture, a slowdown in specialty therapy starts, or a dip in refill adherence at a clinic-owned location are all conditions VytlAIQ can surface before they register as a trend leadership has to explain. When those signals appear, the platform brings them forward with enough context to understand what is happening, where, and what options exist to address it.

That early visibility changes how leadership teams operate. Rather than reacting to performance problems after the fact, they are positioned to make small, targeted adjustments that keep programs on track. Over time, that shift from reactive to proactive management has a meaningful impact on program performance, patient retention, and the financial health of the programs the health system depends on.

3. AI surfaces pharmacy program opportunities you’re missing

Health systems often do not know what they are missing until the data is organized to show them. VytlAIQ uses predictive analytics to identify underutilized opportunities across all three program types: 340B-eligible prescriptions that are not being captured, patients who miss the chance to fill at the health system retail pharmacy, and specialty therapy candidates being referred out of network.

For example, a health system may have a strong oncology program but route specialty patients to an external partner by default rather than capturing them in its own specialty pharmacy. VytlAIQ can identify that pattern, quantify the financial and clinical impact, and help leadership make the case for an operational change. These are not hypothetical opportunities. They are real gaps that exist in most health system pharmacy programs and are difficult to see without the right analytical lens.

4. AI spots patient leakage before it becomes a loss

Patient leakage occurs when a patient fills a prescription outside the health system’s pharmacy network. It is one of the most persistent and costly challenges pharmacy leaders face, and historically, identifying it required manual data pulls and retrospective analysis that arrived too late to act on.

VytlAIQ changes that by continuously analyzing patient prescription activity across 340B, outpatient retail, and specialty programs, identifying patterns that signal leakage risk before a patient is lost. For example, a patient discharged from a health system clinic who has not filled a follow-up prescription within an expected window can be flagged automatically, giving the care and pharmacy team a chance to re-engage. For 340B programs specifically, every prescription that leaves the network is a missed opportunity to capture savings that fund critical patient services.

5. AI supports better decisions about your pharmacy programs’ future

The most valuable use of AI in health system pharmacy is not describing what has happened. It is helping leadership decide what comes next. VytlAIQ combines historical performance data, predictive modeling, and the ability to ask the platform a direct question, giving leaders the context to think strategically about their programs. For 340B leaders, that means assessment and planning supported by visibility into program compliance, savings generation, eligible prescription capture rates, and change risk modeling. For outpatient retail and specialty programs, it means fill rates, patient leakage, adherence benchmarks, and revenue performance, plus the unique attributes affecting each.

Whether a health system is evaluating whether to expand its retail pharmacy reach, change its 340B program structure, or invest in specialty pharmacy growth, those decisions benefit from clean, organized, AI-interpreted data. VytlAIQ is designed to meet health system leaders wherever they are, whether managing day-to-day operations or planning three years out.

The future of health system pharmacy is one where AI handles the complexity of data aggregation and pattern recognition, freeing health system, pharmacy, and operational leaders to focus on what only people can do: building relationships, driving strategy, and delivering better outcomes for patients.

Frequently asked questions

What is pharmacy analytics?

Pharmacy analytics is the practice of collecting and interpreting data across a health system’s pharmacy programs, including 340B, outpatient retail, specialty, and clinic-owned, to measure performance, catch risks early, and guide decisions. AI platforms like VytlAIQ consolidate that data into one real-time view.

How does AI help manage 340B programs?

AI connects 340B platform data with dispensing and patient records to track eligible prescription capture, savings generation, and compliance, and to flag leakage and missed capture before savings are lost.

What is patient leakage in health system pharmacy?

Patient leakage is when a patient fills a prescription outside the health system’s own pharmacy network. AI can flag leakage risk early, for example when a discharged patient has not filled a follow-up prescription, so teams can re-engage.

What is VytlAIQ?

VytlAIQ is VytlOne’s AI-powered pharmacy intelligence platform for health system leadership. It unifies data across 340B, outpatient retail, specialty, and clinic-owned pharmacy programs to deliver real-time analytics, predictive insights, and decision support.

See VytlAIQ in action

Health system pharmacy programs are sitting on data that could be driving better decisions today. VytlAIQ was built to unlock that potential across 340B, outpatient retail, specialty, and clinic-owned pharmacy programs in one integrated platform.

Request a demo and see how VytlAIQ gives health system pharmacy leadership the insight to move forward with confidence.

Heather Brooks is a pharmacist and the Vice President of Pharmacy Services Products at VytlOne. She has over 30 years of experience across retail pharmacy, hospital pharmacy, and pharmacy operations. As a pharmacist, Heather believes in AI as a partner in healthcare, working alongside professional judgment. As an operational leader, she’s focused on what that partnership makes possible: leaner processes, faster throughput, and better use of every dollar and every hour.

Why AI Won’t Replace Pharmacists

By Heather Brooks, Vice President, Pharmacy Services Products, VytlOne

Will AI replace pharmacists? No. In health system pharmacy, AI is augmenting the team, not replacing it. It takes on documentation, data gathering, and routine checks, while pharmacists, pharmacy technicians, and Prescription Access Liaisons (PALs) keep authority over clinical decisions, patient counseling, and care. What staff working alongside these tools describe is not replacement but relief: relief from documentation overload, from hours on hold with insurance companies, and from the mental weight of catching errors in a high-volume, high-stakes environment.

The concern is understandable. AI is moving fast, the headlines are loud, and no one wants to feel like their expertise is being automated away. But the professionals who work with AI day to day are not being pushed out. They are being freed up to do the work only a trained, caring human can do. Here are five ways AI is making that difference.

The five ways at a glance

• AI streamlines the prior authorization process for pharmacy staff.
• AI adds a second layer of error checking in high-volume dispensing.
• AI puts complete medication history at every role’s fingertips.
• AI supports clinical decisions with real-time evidence.
• AI reduces administrative burden so staff can focus on patients.

1. AI streamlines the prior authorization process for pharmacy staff

Prior authorizations (PAs) are one of the most time-consuming, frustrating parts of pharmacy work, and one of the most consequential for patients. A delayed PA can mean a delayed therapy start, a gap in critical medication, or a patient who walks away from care they need. This is especially true in health system specialty pharmacy, where PA volume is high. AI is changing the pace by pulling a patient’s medication history, diagnosis codes, clinical documentation, and payer-specific criteria into one place. That consolidation helps PALs, pharmacists, and pharmacy techs build stronger, faster PA submissions without the hours-long hunt across multiple systems.

How this works in practice

A patient arrives to pick up a newly prescribed specialty medication and learns their insurance requires a prior authorization before it can be dispensed. The PAL opens the workflow, and within minutes AI has surfaced the patient’s relevant diagnosis history, current medication list, prior therapy attempts, and the specific clinical criteria the payer requires, all without a phone call to track down records. The pharmacist reviewing the case uses that same medication history to confirm the new therapy is appropriate given what the patient already takes. The PA is submitted the same day. The patient, who expected a days-long wait, gets a call that afternoon with an update and leaves trusting the pharmacy team is in their corner.

2. AI reduces errors in high-volume dispensing

The dispensing environment in health system retail and specialty pharmacy is fast-moving and unforgiving. Medication errors, even small ones, can have serious consequences, and the cognitive load on dispensing pharmacists and pharmacy techs is significant. AI-assisted verification tools give those teams an additional layer of review that does not get tired, distracted, or have a bad day. By flagging potential drug interactions, dose discrepancies, or duplicate therapies before a medication leaves the pharmacy, AI acts as a reliable second check. The pharmacist’s judgment is not replaced. A supportive backstop helps catch what human eyes sometimes miss.

How this works in practice

A pharmacy tech is processing a high volume of prescriptions during a busy afternoon when a new order comes through for a patient already on a complex regimen. The tech prepares the medication and routes it for pharmacist verification. Before the dispensing pharmacist completes the check, the AI verification system flags a potential interaction between the new prescription and a medication the patient takes for a chronic condition, one filled at a different location that might not have been visible in the active queue. The pharmacist confirms the interaction is clinically significant and contacts the prescribing provider to discuss an alternative. The prescription is updated before it reaches the patient. What could have been a harmful outcome becomes a routine clinical intervention.

3. AI puts complete medication history at every role’s fingertips

A patient’s medication history is foundational to nearly every decision in health system pharmacy, and accessing it has historically been anything but simple. Information lives across systems, visits, and providers, and pulling a complete picture together takes time pharmacy staff often do not have. AI changes this by aggregating and presenting medication history in a structured, accessible format, and the benefit reaches every role on the team. When all roles share the same complete picture, handoffs are smoother, assessments are more thorough, and patients work with a team that knows their history.

How this works in practice

A patient is being discharged with a new prescription added during their inpatient stay. The pharmacist conducting discharge medication reconciliation needs to evaluate whether the new therapy is safe alongside the medications the patient took before admission, prescribed by specialists, a community pharmacy, and a mail-order service. Instead of piecing that history together from multiple portals and phone calls, the AI tool surfaces a consolidated medication list in seconds. The pharmacist identifies a duplication of therapy and resolves it before discharge. The patient goes home with the right medications, the right instructions, and a care team working from the same page.

4. AI clinical decision support surfaces real-time evidence

Pharmacists apply an enormous breadth of knowledge in real time: dosing adjustments based on kidney or liver function, drug interaction management, therapeutic alternatives, and formulary considerations that change with each payer. Staying current with clinical guidelines while managing an active caseload is one of the most demanding parts of the role. AI tools that surface relevant clinical evidence, guideline summaries, and decision-support prompts at the point of care reduce that cognitive load without reducing the pharmacist’s authority. The pharmacist still makes the clinical decisions, now with better, faster access to the information that supports them.

How this works in practice

A pharmacist is consulted on a patient whose new prescription requires a dose adjustment due to reduced kidney function found in recent lab work. The pharmacist needs to determine the appropriate dose, confirm there are no additional interaction concerns given the patient’s other medications, and document the recommendation. The AI clinical decision-support tool surfaces the relevant dosing guidance, flags a secondary interaction that warrants monitoring, and pulls the current guideline supporting the adjustment. The pharmacist reviews, applies clinical judgment, and delivers a recommendation to the provider in a fraction of the usual time. The patient’s therapy starts safely and on time.

5. AI reduces administrative burden so staff can focus on patients

Ask anyone in health system pharmacy what they wish they had more time for, and the answer is almost always the patient. The work that drew most pharmacy professionals to the career, counseling someone on a new medication, advocating for access to a therapy, and building the relationship that makes a patient feel cared for, is also the work most likely to get crowded out by administrative demands. AI reclaims that time by streamlining documentation, triaging routine inquiries, and handling the repetitive workflows that quietly consume hours of the day.

How this works in practice

A patient arrives to pick up a new therapy with important instructions, potential side effects, and follow-up steps to understand before leaving. Normally the dispensing pharmacist is already behind, with prescriptions queued for verification, a phone ringing at the counter, and unfinished documentation from earlier. But because AI has handled documentation consolidation for new therapies and reduced manual research on several drug-drug interactions, the pharmacist’s queue is manageable. The pharmacist has the time and bandwidth to work with the patient and make sure they understand their new medication, building trust and improving adherence.

Where this is heading

Across all five areas, AI is moving from reactive to proactive. Prior authorization is heading toward real-time eligibility checks at the point of prescribing and automated status tracking, turning a days-long process into hours. Verification is moving toward predictive risk modeling and AI-enhanced imaging that catches labeling and selection errors under real-world conditions like glare, poor lighting, and awkward angles. Medication history tools are starting to flag gaps and missing records, not just aggregate what exists. Clinical decision support is becoming proactive, surfacing guideline updates and patients due for review before anyone asks. And documentation is increasingly handled by natural language processing that turns clinical interactions into structured notes with minimal staff input. The through-line is the same: AI takes the work that can be automated so pharmacy staff can spend their time where only a human can.

The bottom line

AI in health system retail and specialty pharmacy will not replace the expertise, judgment, and compassion that pharmacy professionals bring to their work. What it can do is take on the administrative tasks that drain those qualities, the documentation and the data gathering. For pharmacists, PALs, and pharmacy techs, the promise of AI is a more supported team, not a smaller one. It is a team where errors are caught before they reach a patient, prior authorizations move faster, and information is readily available, so patient care stays front and center and the daily administrative frustrations of pharmacy practice are muted.

Frequently asked questions

Will AI replace pharmacists?

No. AI augments pharmacists rather than replacing them. It handles documentation, data gathering, and routine checks, while pharmacists keep authority over clinical decisions, counseling, and patient care.

Will AI replace pharmacy technicians?

No. AI takes on repetitive workflows like record retrieval and verification support, which frees pharmacy technicians and Prescription Access Liaisons for higher-value work rather than eliminating their roles.

Will AI take over pharmacy?

The realistic near-term picture is augmentation, not takeover. AI catches errors, speeds prior authorizations, and reduces administrative load, while trained professionals make the judgment calls patient safety depends on.

How is AI used in health system pharmacy today?

AI is used to streamline prior authorizations, add a second layer of error checking in dispensing, consolidate medication history, surface clinical evidence at the point of care, and cut administrative burden so staff can focus on patients.

See how VytlAIQ supports health system pharmacy teams.

Request a demo.

Heather Brooks is a pharmacist and the Vice President of Pharmacy Services Products at VytlOne. She has over 30 years of experience across retail pharmacy, hospital pharmacy, and pharmacy operations. As a pharmacist, Heather believes in AI as a partner in healthcare, working alongside professional judgment. As an operational leader, she’s focused on what that partnership makes possible: leaner processes, faster throughput, and better use of every dollar and every hour.

By Heather Brooks, Vice President, Pharmacy Services Products, VytlOne

How is AI improving the specialty pharmacy patient journey? AI is helping health system specialty pharmacies make the medication journey simpler, faster, safer, and more affordable, improving medication access at every step. It flags affordability barriers early, speeds prior authorizations, closes refill gaps, coordinates care across clinic and payer, and surfaces safety risks sooner, with pharmacists and care teams reviewing every step. The strongest results come from AI working alongside integrated clinic and pharmacy care teams and the patient.

In health system outpatient retail and specialty pharmacy, the patient journey includes coverage checks, prior authorizations (PAs), medication therapy management, refills, delivery, and human support. Below are five ways AI is improving that journey.

The five ways at a glance

• Affordability support becomes proactive instead of reactive.
• Prior authorization moves from fax-and-wait to a guided, faster submission.
• Refills and reminders close adherence gaps before they form.
• Care feels coordinated across clinic, pharmacy, and payer.
• Safety risks are flagged earlier, with humans in the loop.

1. AI makes medication affordability proactive

One of the biggest patient stressors is cost uncertainty, particularly for specialty therapies where copays can be high and assistance programs are complex. That same specialty complexity is where the 340B revenue most health systems miss tends to concentrate. In strong health system models, affordability support is already core to the care experience: identifying copay assistance, coordinating financial support, and setting expectations early. AI makes that support faster and more consistent by flagging likely affordability barriers, prioritizing who needs help first, and prompting the right assistance pathways at the right moment, before a patient abandons therapy.

How this works in practice

Marisol arrives at the pharmacy counter expecting a routine pickup. The initial copay is far higher than she expected. Instead of being told to check back, the pharmacy has proactively come up with two options: an assistance pathway and a clinically appropriate alternative to discuss with the clinic. The result is not that AI saved the day, but less panic, fewer delays, and a plan that supports her access to medication.

2. AI speeds prior authorization in specialty pharmacy

For specialty pharmacy patients, delays in prior authorization mean delays in therapy. PAs can take several days and sometimes longer, which is why time to therapy shows up as a top metric in specialty pharmacy performance. AI helps by drafting payer questionnaire responses, extracting relevant clinical evidence, and reducing the time staff spend rekeying information. AI can reduce work time per authorization from as much as 25 minutes to about five minutes, and submissions can go in about a day earlier.

How this works in practice

Darryl is prescribed a new, high-cost injectable after a flare-up. Historically, starting this drug takes weeks. VytlOne’s Prescription Access Liaisons can use AI-assisted drafting of the PA, shortening the time between prescribed and in hand. The pharmacist reviews for accuracy, and the request goes out sooner. The patient sees the care plan moving forward instead of stuck in paperwork.

3. AI closes refill gaps and improves medication adherence

Nonadherence often is not dramatic. It is small gaps: a refill missed during a busy week, a pickup delayed, a message forgotten. Digital reminders and nudges, especially text-based ones, are patient-friendly, scalable ways to reduce refill gaps, one of several medication adherence solutions AI makes smarter. AI makes this smarter by timing outreach based on behavior patterns, channel preference, and risk signals rather than a fixed day 28 text, and it does so without burying pharmacy staff in manual calls.

How this works in practice

Sam manages diabetes medications, blood pressure medications, and a statin, along with work and family. An AI-supported refill program notices a refill gap forming, sends a gentle nudge, and offers a quick deliver-or-pickup option. Sam stays on track without spending 30 minutes on hold.

4. AI coordinates care across clinic, pharmacy, and payer

Patients often experience the system as fragmented: the clinic says one thing, the payer says another, and the pharmacy is left translating. VytlOne’s health system specialty pharmacy models emphasize coordination by embedding Prescription Access Liaisons in provider offices, which allows for consistent updates and fewer dropped handoffs. AI improves coordination by acting like a workflow air traffic controller: routing tasks, flagging missing information, and keeping statuses visible so the next best action is obvious to the team, the same shift toward action that AI-driven pharmacy analytics brings to health system leadership. That visibility and orchestration turns a chaotic journey into a predictable one.

How this works in practice

The prescriber tells Nina the pharmacy will have her prescription ready. Instead of arriving to learn the prescription must be changed to the insurance formulary product, Nina gets predictable updates: benefits verified, PA submitted or alternates discussed with the prescriber, assistance in progress, delivery scheduled. Her journey from prescriber to medication in hand is handled with white-glove service.

5. AI flags medication safety risks earlier, with humans in the loop

Medication safety is not just dispensing accuracy. It also includes duplicate therapies, wrong-dose risks, and missed clinical signals. AI can flag potential problems early, and the critical design point is human review, which allows for proactive discussions among the prescriber, pharmacist, and patient.

How this works in practice

George has a medication change after a hospitalization. The system flags a possible duplication risk with a home medication. The pharmacist confirms with George that he has the duplicate at home, and the final regimen accounts for it while avoiding duplicative therapy. George feels someone is paying attention, and his confidence in his care team rises.

Where this is heading

Across all five areas, AI is shifting specialty pharmacy from reactive to anticipatory. Expect affordability support to move closer to real time, predicting cost barriers before a prescription is finalized. Prior authorization is trending toward proactive readiness, with AI predicting friction and helping teams build the approval packet upfront. Refill support is becoming anticipatory, catching insurance changes and shipment constraints before they become emergencies. Coordination is getting more structured, and safety is moving toward continuous medication surveillance that points pharmacists to the highest risk first.

A better experience, because the basics work better

Health system outpatient retail and specialty pharmacies are already positioned differently: closer to the clinic, connected to the care plan, and built to support medication access end to end. Used well, AI strengthens this model. Cost conversations happen earlier, authorizations move with fewer delays, refills do not slip into gaps, and safety risks are flagged sooner. The patient journey becomes more predictable and supported, and pharmacy teams get more time back for counseling and problem-solving instead of paperwork.

5 Things Pharmacy Leaders Should Learn

By Kim Tzoumakas, CEO, VytlOne

Building AI in health system pharmacy means putting the operational foundation in place first and then using AI to amplify it. In practice, that means AI works best when it augments experienced pharmacy teams rather than replacing them: catching compliance gaps before they become denials, handling repetitive work, and freeing pharmacists and liaisons to spend their judgment where it changes patient outcomes. The technology is rarely the obstacle. Operational clarity is.

Technology is never really the hard part. I wish it were because that would make my job easier. The hard part is sequencing, culture, and building the operational foundation that technology can amplify.

I spent years working inside health systems, early on as an attorney advising on strategy, hearing the same conversations again and again: not enough capital to improve outcomes or provide critical services. The 340B compliance gaps I saw were rarely about bad intentions. They came from programs outpaced by complexity and heavy regulatory change, moving faster than teams could manage. I watched health systems lose money they didn’t have to lose, or take overly conservative stances out of fear of regulatory audits. It stuck with me, and it’s the lens I bring to every leadership decision I make today.

Since then, I’ve had the privilege of leading transformation and growth across three very different multi-state healthcare organizations: oncology, radiology, and now pharmacy. These are different clinical worlds, but the same lesson keeps showing up. The technology is rarely the obstacle. Operational clarity and focus are. Get those right and success tends to follow almost naturally. Skip them and AI just helps you move faster in the wrong direction.

Why 340B complexity makes the operational foundation non-negotiable

The 340B program has grown far more complex. There are manufacturer restrictions, audit exposure, and contract pharmacy scrutiny. All of it lands on teams that are also trying to take care of patients every day, often with limited resources. When I joined VytlOne, I found a pharmacy operational team with real depth. What we didn’t have 18 months ago was one unified platform that could work across all of pharmacy operations with the speed and visibility this moment needs.

Building VytlAIQ ourselves, rather than buying something and bolting it on, was deliberate. What we had at the start was unique and would set us apart: a century of pharmacy history, three decades of managing health system pharmacies, and operational data that is real, clean, and ours.

When a health system leader is skeptical of AI, I understand it, and it usually works in our favor. We did not want to be a technology player chasing short-term wins. Instead, we built a platform to augment teams in hospitals as experienced as the ones inside VytlOne. There is a real difference between AI shaped by people who have actually run 340B workflows and a product built by a technology player.

Where AI transformation stalls in health systems

Most transformation struggles in the space between a confident technology decision and the operational reality underneath it. What I am proudest of with VytlAIQ is not the technology itself. It is what it frees people to do: catch the small things that would otherwise become denials or missed opportunities, and quietly handle the work that used to consume pharmacists’, liaisons’, and compliance teams’ time. It does not replace people. It gives them room to use their judgment where it matters most, which is keeping patients on their medicines and delivering care that technology alone never will.

What I’ve come to believe about AI and pharmacy margin

Culture shapes how well technology lands. The hardest conversations are often with the people in the trenches who do not have the bandwidth to assess how the right resources and partners could strengthen operations they have already made successful. That assessment should never feel like a threat or a sign of failure. It reflects leadership and financial rigor at the moment hospitals need both most.

Pharmacy should be driving significant investment in every hospital through the margin it can generate. Without those dollars, patients suffer and services lag across the healthcare system. VytlAIQ exists to augment and support pharmacy teams so they can generate the margin that lets hospitals reinvest in critical programs.

Key Takeaways

• In health system pharmacy, the operational foundation, not the technology, decides whether AI delivers.
• 340B complexity (manufacturer restrictions, audit exposure, contract pharmacy scrutiny) makes that foundation non-negotiable.
• VytlOne built VytlAIQ in house to augment experienced pharmacy teams, not replace them.
• Done right, AI in health system pharmacy protects margin, and that margin lets hospitals reinvest in patient care.

FAQs

What does building AI in health system pharmacy actually require?
It requires an operational foundation first. AI amplifies whatever process it lands on, so operational clarity has to come before the technology. Without it, AI just accelerates existing problems.

Does AI replace pharmacists in health systems?
No. Used well, AI in health system pharmacy augments pharmacists, liaisons, and compliance teams by handling repetitive work and catching issues early, which frees them to apply clinical judgment where it most affects patient outcomes.

How does AI in health system pharmacy affect 340B compliance?
It helps teams keep pace with 340B complexity, including manufacturer restrictions, audit exposure, and contract pharmacy scrutiny, by surfacing gaps before they become denials or missed opportunities.

How does AI in health system pharmacy support hospital margin?
By protecting the margin pharmacy generates, AI helps hospitals reinvest in critical programs and services. The goal is not cost-cutting; it is freeing skilled teams to generate value.

Kim Tzoumakas is the CEO of VytlOne. 

5 Things Pharmacy Leaders Should Learn

By Joel Wright, President of Pharmacy Services, VytlOne

Artificial intelligence (AI) is moving from pilot projects into the core of pharmacy operations. In health system pharmacy and 340B programs, that shift carries more weight than almost anywhere else, because here AI touches patient access, compliance risk, and the use of limited resources across vulnerable populations.

After working inside these programs, the lesson I keep returning to is simple. The value of AI is not decided by how advanced it is. It is decided by how thoughtfully it is governed and how closely it stays tied to patient outcomes.

Here are five things every pharmacy leader should learn before adopting it.

1. AI in pharmacy is a governance decision, not a technology purchase

Most technology decisions reside within IT. AI in a health system-owned pharmacy extends far beyond technology, enabling smarter patient outreach, more effective resource allocation, and greater visibility into 340B opportunities. As AI becomes a strategic driver of outcomes, governance is what makes sure that innovation is applied responsibly and consistently.

Effective governance includes:

• Clear accountability for AI-enabled decision support.
• Oversight of any model that influences outreach or prioritization.
• Continuous monitoring for differential effects across patient populations and payer types.
• Transparency about how recommendations are generated.
• The ability for pharmacists and clinicians to override automated guidance.

Before you evaluate a single feature, answer one question. When AI influences a decision, who is accountable for it?

2. Responsible AI should reduce bias and widen access, not narrow it

AI has the power to enhance decision-making and operational performance. With the right governance and design principles, organizations can proactively address potential biases and support more consistent outcomes.

Designed responsibly, AI does the opposite of what people fear. By expanding the data signals it considers, incorporating human oversight, and regularly testing for unintended disparities, it can surface patients who might otherwise be missed, including those who are newly diagnosed or facing barriers like affordability and access. That same visibility is what surfaces the 340B revenue most health systems miss, the eligible cases manual screening skips over. In a pharmacy that sits inside the clinical care continuum, that capability lets an organization extend access more intentionally and strengthen patient trust.

3. The point of AI is action, not better reports

Traditional pharmacy analytics are good at explaining what already happened. Revenue and cost trends, capture rates, adherence percentages. What reporting rarely tells a team is what to do next.

For AI to change that, it has to be grounded in a holistic data strategy. Most of the data that supports pharmacy decisions is scattered across clinical systems, pharmacy platforms, payer feeds, and financial tools, or never captured at all. Connecting those sources, and delivering insight in time to influence care, is the foundation.

The next evolution of pharmacy intelligence surfaces issues while prescriptions and referrals are still upstream, prioritizes intervention based on clinical and operational context, and routes work to the right team members. That move from hindsight to insight is where AI starts to earn its place.

4. Human review is the most important design point

The most important design point in any responsible system is human review. AI can surface insights and opportunities, but clinicians and pharmacy teams remain responsible for every care and operational decision.

Pharmacists and clinicians need a real ability to override automated recommendations, not a checkbox that exists on paper. That is what keeps AI aligned with pharmacy operations, 340B requirements, and patient safety, while still accelerating the work.

5. Where your AI comes from matters

As adoption accelerates, the source of the intelligence matters as much as the intelligence itself. Many of the solutions entering the market today are built by strong engineering teams with no pharmacists, no 340B compliance depth, and no history operating inside the complexity of a health system.

The foundation needs to be built and validated by pharmacists and operators who have actually worked inside the systems the technology intends to serve.

That is the thinking behind VytlAIQ, our AI enabled pharmacy intelligence platform built specifically for health system environments. It is designed around continuous 340B eligibility review, real time performance visibility across pharmacy operations, workflow automation, and next best action guidance to support clinical decision making. The point is not the feature list. The point is that responsible AI shows up as integrated workflows and data models aligned with compliance, care delivery, and equity goals.

Looking ahead: responsible AI and sustainable 340B performance

AI has real potential to help health system pharmacies navigate the growing complexity of 340B, specialty pharmacy, and access management. Its value will not be determined by sophistication alone. It will be determined by how thoughtfully it is governed, how transparently it operates, and how closely it remains tied to patient outcomes.

For organizations willing to lead with accountability and clinical oversight, AI becomes a tool that supports sustainable 340B program optimization while advancing the core mission of equitable, high-quality care.

A VytlOne Member Services Success Story

What is responsible AI in pharmacy?

Responsible AI in pharmacy means using artificial intelligence to support pharmacy teams, not replace them. Trained people stay in the loop on consequential decisions, member data is protected under the Health Insurance Portability and Accountability Act (HIPAA), and the technology’s limits and potential for bias are disclosed openly. The goal is better care, guided by people. That’s part of a broader shift health systems are watching closely: AI governance in healthcare, meaning who reviews an AI system’s decisions, what data it touches, and how vendors disclose its limits.

Summary

• VytlOne leverages AI in its contact center to enhance human connection, streamline tasks, and provide member advocates with insights, enabling them to focus on engaging and problem-solving for members.
• AI analyzes conversations to identify trends and delivers real-time coaching, resulting in continuous improvement, reduced member abrasion, and high member satisfaction scores.
• The company is implementing AI-powered call summarization to further improve efficiency, consistency, and personalized member experiences by freeing staff from manual notetaking.

The impact of AI

At VytlOne, we’re using artificial intelligence (AI) to strengthen the human connection in our contact center. AI enables our highly trained member advocates by streamlining tasks and surfacing insights, which allows our team to focus on what matters most: listening, engaging, and solving problems for our members.

How we’re using AI today

 AI transcribes and analyzes calls to identify meaningful conversation “moments,” grouping common topics and inquiries. These insights help us proactively identify trends, deliver real-time coaching, and focus resources where they are needed most. This is one example of responsible AI in pharmacy: the technology handles the pattern-finding, and skilled people handle the care. The results speak for themselves:

4.89 out of 5.0 member satisfaction based on more than 50,000 surveys in 2025.

What’s next?

VytlOne is implementing AI-powered call summarization to free advocates from manual notetaking, increase documentation consistency and quality, and enable faster resolutions. Most importantly, this provides team members additional time for active member connection and personalized, high-touch experiences.

For a closer look at how we govern these tools across our pharmacy programs, read “Responsible AI in Pharmacy: VytlOne’s Approach”

If you’d like to learn more about how VytlOne supports members through innovation and care, reach out to your VytlOne representative.

Introducing VytlAIQ

Have you heard about VytlAIQ, our new end-to-end intelligence platform designed for health system 340B and specialty pharmacy services?

VytlAIQ unifies data, automates workflows, and delivers predictive intelligence to help pharmacists and healthcare providers maximize 340B performance, accelerate patient access, and unlock the full value of specialty and pharmacy services.

Learn more about VytlAIQ or schedule a platform briefing to see how AI supports members through innovation and care.

Frequently asked questions

What is responsible AI in pharmacy?

Responsible AI in pharmacy is the practice of using artificial intelligence to support pharmacy and member-services teams rather than replace them. It keeps trained people in charge of consequential decisions, protects member data under HIPAA, and stays transparent about what the technology can and cannot do, including its potential for bias. At VytlOne, that means AI handles the pattern-finding and routine tasks so member advocates can spend more time listening, problem-solving, and building trust with the people they serve.

How does AI help pharmacy contact centers?

In a pharmacy contact center, AI transcribes and analyzes calls to surface common questions, recurring themes, and coaching opportunities across thousands of interactions. Those insights help teams spot trends early, deliver real-time coaching, and direct resources where members need them most. AI can also summarize calls automatically, which reduces manual notetaking and speeds up follow-up. The result is more consistent documentation and more time for advocates to focus on the member in front of them.

How does AI affect the member experience?

Used responsibly, AI improves the member experience by removing friction, not adding it. By handling transcription, analysis, and summarization behind the scenes, it frees member advocates to give fuller attention to each conversation. VytlOne earned a 4.89 out of 5.0 member-satisfaction score across more than 50,000 surveys in 2025, evidence that pairing AI with skilled people supports high-touch, personalized service rather than replacing it.

Is AI in pharmacy contact centers HIPAA-compliant?

It can be, and it should be. Any AI used in a pharmacy contact center must handle protected health information under HIPAA safeguards, with appropriate access controls, encryption, and vendor agreements in place. At VytlOne, responsible AI also means human oversight on consequential decisions and transparency about the technology’s limits. Member privacy and safety come first, and the technology is held to the same standard of care as the people who use it.

How does VytlOne approach AI governance in healthcare?

VytlOne treats AI governance in healthcare as a leadership responsibility, not a technical afterthought. Every AI tool we use goes through review for HIPAA compliance, bias testing, and human oversight before it reaches a member conversation.